Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 25.70M | £ 24.30M | £ 25.10M | £ 25.70M | £ 21.50M |
Total Assets | £ 377.60M | £ 378.50M | £ 327.30M | £ 377.10M | £ 349.00M |
Total Debt | £ 124.00M | £ 106.80M | £ 81.00M | £ 89.90M | £ 51.10M |
Net Debt | £ 98.30M | £ 82.50M | £ 55.90M | £ 64.20M | £ 29.60M |
Total Liabilities | £ 288.20M | £ 216.70M | £ 194.10M | £ 265.70M | £ 219.00M |
Stockholders Equity | £ 70.00M | £ 143.80M | £ 115.70M | £ 95.00M | £ 113.30M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |